{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T18:09:45Z","timestamp":1774634985424,"version":"3.50.1"},"reference-count":42,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2026,3,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intra-arterial chemotherapy (IAC) has emerged as a minimally invasive treatment modality for globe salvage in patients with retinoblastoma (Rb). There is limited knowledge of the factors that influence rates of enucleation after IAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Our study identifies predictors of enucleation among Rb patients receiving IAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective study of Rb patients who received IAC between January 2010 and December 2024 at a single center in the United States. The primary outcome was enucleation at last follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 305 patients, 26.89% (n=82) underwent enucleation and 73.11% (n=223) did not. On multivariate analysis, factors associated with increased risk for enucleation were greatest basal diameter (OR 1.07, 95%\u2009CI 1.00 to 1.15, p=0.035), bilateral Rb (OR 2.82, 95%\u2009CI 1.36 to 5.81, p=0.005), and advanced-stage disease at presentation (OR 7.45, 95% CI 1.92 to 28.9, p=0.004). The use of combination chemotherapy was associated with lower odds for enucleation compared with single-agent chemotherapy (OR 0.29, 95%\u2009CI 0.11 to 0.80, p=0.016), whereas double-agent chemotherapy was not significantly associated with enucleation (OR 0.90, 95%\u2009CI 0.46 to 1.75, p=0.75).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Larger tumors, bilateral disease, and advanced-stage disease were linked to higher odds of enucleation, whereas combination chemotherapy was associated with lower odds compared with single-agent chemotherapy. Future studies could help validate these results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnis-2026-025227","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:20:35Z","timestamp":1774632035000},"page":"jnis-2026-025227","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of enucleation after intra-arterial chemotherapy for retinoblastoma"],"prefix":"10.1136","author":[{"given":"Joanna","family":"Roy","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9479-761X","authenticated-orcid":false,"given":"Victor Gabriel","family":"El-Hajj","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taweevat","family":"Attaseth","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Pan","sequence":"additional","affiliation":[{"name":"School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basel","family":"Musmar","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady Bassem","family":"Fayek","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wi Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1054-9414","authenticated-orcid":false,"given":"Stavropoula I","family":"Tjoumakaris","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7797-1935","authenticated-orcid":false,"given":"Reid","family":"Gooch","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H","family":"Rosenwasser","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab","family":"Alshahrani","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"},{"name":"Neurosurgery, Trillium Health Partners, Mississauga, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1544-4910","authenticated-orcid":false,"given":"Pascal","family":"Jabbour","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2026032710202412000_jnis-2026-025227v1.1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3928\/01913913-20200417-01","article-title":"Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients","volume":"57","author":"Dalvin","year":"2020","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2026032710202412000_jnis-2026-025227v1.2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/292734"},{"key":"2026032710202412000_jnis-2026-025227v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa142"},{"key":"2026032710202412000_jnis-2026-025227v1.4","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2019-014909"},{"key":"2026032710202412000_jnis-2026-025227v1.5","unstructured":"Kaur K , Patel BC . Retinoblastoma. In: StatPearls. Treasure Island, FL: StatPearls Publishing, 2025."},{"key":"2026032710202412000_jnis-2026-025227v1.6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1017\/S1478951519000920","article-title":"Impact of enucleation on adult retinoblastoma survivors\u2019 quality of life: A qualitative study of survivors\u2019 perspectives","volume":"18","author":"Banerjee","year":"2020","journal-title":"Palliat Support Care"},{"key":"2026032710202412000_jnis-2026-025227v1.7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41433-025-04144-y","article-title":"Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries","volume":"40","author":"Bowman","year":"2026","journal-title":"Eye (Lond)"},{"key":"2026032710202412000_jnis-2026-025227v1.8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.oret.2025.02.013","article-title":"Intra-arterial Chemotherapy for Retinoblastoma, Outcomes Analysis in 357 Eyes: Thirteen Years of Experience in a Referral Center in Brazil","volume":"9","author":"Teixeira","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"2026032710202412000_jnis-2026-025227v1.9","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6590"},{"key":"2026032710202412000_jnis-2026-025227v1.10","doi-asserted-by":"crossref","unstructured":"Fulton AT , Maniar A , Provenzano A , et al . Comparison of single- versus multi-drug treatment for intra-arterial chemotherapy (IAC) in children with retinoblastoma. Interv Neuroradiol 2025:15910199251324028. doi:10.1177\/15910199251324028","DOI":"10.1177\/15910199251324028"},{"key":"2026032710202412000_jnis-2026-025227v1.11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2147\/OPTH.S24318","article-title":"Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding","volume":"5","author":"Kim","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"2026032710202412000_jnis-2026-025227v1.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145436","article-title":"Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC","volume":"10","author":"Abramson","year":"2015","journal-title":"PLoS One"},{"key":"2026032710202412000_jnis-2026-025227v1.13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40942-017-0093-8","article-title":"Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide","volume":"3","author":"Abramson","year":"2017","journal-title":"Int J Retin Vitr"},{"key":"2026032710202412000_jnis-2026-025227v1.14","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2019-015627"},{"key":"2026032710202412000_jnis-2026-025227v1.15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3171\/2025.8.PEDS25313","article-title":"Transradial versus transfemoral access for pediatric intra-arterial chemotherapy for retinoblastoma","volume":"37","author":"Roy","year":"2025","journal-title":"J Neurosurg Pediatr"},{"key":"2026032710202412000_jnis-2026-025227v1.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2024.01.013","article-title":"Association of Neighborhood Opportunity With Severity of Retinoblastoma at Presentation","volume":"261","author":"Altamirano-Lamarque","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"2026032710202412000_jnis-2026-025227v1.17","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-1069"},{"key":"2026032710202412000_jnis-2026-025227v1.18","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28757","article-title":"Socioeconomic status and retinoblastoma survival: Experience of a tertiary cancer center in Brazil","volume":"68","author":"Mattosinho","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"2026032710202412000_jnis-2026-025227v1.19","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2214-109X(21)00555-6","article-title":"Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors","volume":"10","author":"Wong","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026032710202412000_jnis-2026-025227v1.20","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.150"},{"key":"2026032710202412000_jnis-2026-025227v1.21","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1177\/1120672120957587","article-title":"Secondary intra-arterial chemotherapy and\/or intravitreal chemotherapy as salvage treatment for retinoblastoma","volume":"31","author":"Mirzayev","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"2026032710202412000_jnis-2026-025227v1.22","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318295f783"},{"key":"2026032710202412000_jnis-2026-025227v1.23","first-page":"961","article-title":"An international survey of classification and treatment choices for group D retinoblastoma","volume":"10","author":"Scelfo","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"2026032710202412000_jnis-2026-025227v1.24","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00417-018-4051-4","article-title":"Retrospective analysis of primarily treated group D retinoblastoma","volume":"256","author":"Kiratli","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026032710202412000_jnis-2026-025227v1.25","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5844-5","article-title":"Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3\u2009months of age","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cancer"},{"key":"2026032710202412000_jnis-2026-025227v1.26","doi-asserted-by":"publisher","DOI":"10.3928\/01913913-20160719-04"},{"key":"2026032710202412000_jnis-2026-025227v1.27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ophtha.2022.04.006","article-title":"High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study","volume":"129","author":"Tomar","year":"2022","journal-title":"Ophthalmology"},{"key":"2026032710202412000_jnis-2026-025227v1.28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ophtha.2022.04.022","article-title":"Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study","volume":"129","author":"Tomar","year":"2022","journal-title":"Ophthalmology"},{"key":"2026032710202412000_jnis-2026-025227v1.29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2021.09.002","article-title":"Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China","volume":"129","author":"Zhou","year":"2022","journal-title":"Ophthalmology"},{"key":"2026032710202412000_jnis-2026-025227v1.30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2026032710202412000_jnis-2026-025227v1.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2011.02296.x"},{"key":"2026032710202412000_jnis-2026-025227v1.32","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-020109"},{"key":"2026032710202412000_jnis-2026-025227v1.33","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-301925"},{"key":"2026032710202412000_jnis-2026-025227v1.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197081","article-title":"Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival","volume":"13","author":"Francis","year":"2018","journal-title":"PLoS One"},{"key":"2026032710202412000_jnis-2026-025227v1.35","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-020170"},{"key":"2026032710202412000_jnis-2026-025227v1.36","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319118"},{"key":"2026032710202412000_jnis-2026-025227v1.37","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016759"},{"key":"2026032710202412000_jnis-2026-025227v1.38","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.5"},{"key":"2026032710202412000_jnis-2026-025227v1.39","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300498"},{"key":"2026032710202412000_jnis-2026-025227v1.40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/joco.joco_113_21","article-title":"Five-Year Experience in Treatment of Retinoblastoma with Intra-Arterial Chemotherapy: A Single-Center Analysis","volume":"33","author":"Ghassemi","year":"2021","journal-title":"J Curr Ophthalmol"},{"key":"2026032710202412000_jnis-2026-025227v1.41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-020-04036-w","article-title":"Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma","volume":"85","author":"Chen","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026032710202412000_jnis-2026-025227v1.42","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41433-020-0898-9","article-title":"A 20-year audit of retinoblastoma treatment outcomes","volume":"34","author":"G\u00fcnd\u00fcz","year":"2020","journal-title":"Eye (Lond)"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2026-025227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:20:40Z","timestamp":1774632040000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2026-025227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":42,"alternative-id":["10.1136\/jnis-2026-025227"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2026-025227","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}